Grifols | GRFS - Trade Creditors

Stock Price
7.86
Daily Change
0.20 2.61%
Monthly
-8.60%
Yearly
1.29%
Q2 Forecast
7.46

Grifols reported EUR987.75M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Alaunos Therapeutics USD 400K 213K Mar/2026
Arca Biopharma USD 4.16M 1.95M Dec/2025
aTyr Pharma USD 2.76M 52.32M Mar/2026
Bio Path USD 4.9M 1.42M Sep/2025
Brainstorm Cell Therapeutics USD 7.32M 250K Mar/2026
Capricor Therapeutics 3.93M 2.27M Mar/2026
Cara Therapeutics USD 3.22M 859K Dec/2025
Esperion Therapeutics USD 68.41M 3.34M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Grifols EUR 987.75M 47.87M Dec/2025
Immunic USD 11.01M 873K Mar/2026
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Minerva Neurosciences USD 640K 305K Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
TherapeuticsMD USD 143K 4K Jun/2024